MedTrace Logo

ImmuneSense Lyme Study

NCT04422314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 893

Last updated 2022-04-15

No results posted yet for this study

Summary

ImmuneSense Lyme is a study, which is designed to better understand the immune response to Lyme disease. This is critically important because the immune system may be able to tell us important information about how our own bodies detect and respond to the disease that current tests cannot. Data collected from this study may accelerate the development of better diagnostics for Lyme disease and improve outcomes for many.

Conditions

  • Lyme Disease

Interventions

DIAGNOSTIC_TEST

T-Detect Lyme

T-Detect Lyme is an investigational use test that uses multiplex PCR and NGS to assess rearranged T-cell receptor beta (TRB) gene sequences from genomic DNA isolated from human peripheral blood.

Sponsors & Collaborators

  • Iqvia Pty Ltd

    collaborator INDUSTRY

  • Adaptive Biotechnologies

    lead INDUSTRY

Principal Investigators

  • Namita Singh, MD · Medical Director, Clinical Development

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-09
Primary Completion
2021-10-29
Completion
2021-10-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04422314 on ClinicalTrials.gov